Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ghrelin-producing cells are specialized endocrine cells, primarily located in the gastric mucosa but also present throughout the gastrointestinal tract and in smaller numbers in organs such as the pancreas and hypothalamus. These cells synthesize and secrete **ghrelin**, a 28-amino-acid peptide hormone, into the bloodstream in response to various physiological cues. Ghrelin acts as an orexigenic (appetite-stimulating) hormone and plays a key role in energy homeostasis, growth hormone release, gastrointestinal motility, glucose metabolism, and several other neuroendocrine functions. The primary molecular target of ghrelin is the **Growth hormone secretagogue receptor (GHSR)**, a G protein-coupled receptor. Ghrelin-producing cells are classified as "closed-type" (not in contact with GI tract lumen) in the stomach and "open-type" (in contact with lumen) elsewhere in the GI tract.
Not applicable for drugs directly targeting the cell; for drugs targeting the ghrelin pathway, typical mechanisms include GHSR agonism or antagonism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ghrelin-producing cell.